foxo4-dri senolytic 2023 2024 study Frontiers FOXO4-DRI part 1 , #peptide
Description
doi: 10.1097/01.rvi.0000092663.72261.37
TrustScore 3.50 Make supplements work for you Get the app to see TrustScore details Nutrients Suggested use: Take 1 softgel daily
AOD-9604 has superior plasma stability (longer half-life) and is the only fragment that completed Phase 2b clinical trials in obesity
Restore Nerves & Blood Vessels Promotes new blood vessel formation and nerve regeneration at injury sites, supporting complete functional recovery rather than just surface-level healing
